|
Contents
|
|
|
|
Astrocytomas
|
|
|
|
E.
Lopez Aguilar, S. Delgado-Huerta, A. C. Sepulveda-Vildosola, V.
Wanzke-Del-angel, H. Rodriguez-Jimenez
Neoadjuvant
chemotherapy with temozolamide plus ifosfamide, carboplatin and etoposide
in pediatric patients with high grade astrocytomas. Phase II study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
463
|
|
Chen B, Ahmed T, Mannancheril A, Gruber M, Benzil DL
Safety and efficacy of high-dose chemotherapy with autologous
stem cell transplantation for patients with malignant astrocytomas
Cancer. 2004 May 15;100(10):2201-7
|
|
|
Brain
Tumors
|
|
|
|
Fiorillo A, Maggi G,
Greco N, Migliorati R, D'Amico A, De Caro MD, Sabbatino MS, Buffardi F
Second-line chemotherapy with the association
of liposomal daunorubicin, carboplatin and etoposide in children with
recurrent malignant brain tumors
J Neurooncol. 2004 Jan;66(1-2):179-85
|
|
R.J.
Strege, Y.J. Liu, A.
Kiely, R.M. Johnson, E.M. Gillis, P. Storm, B.S. Carson, G.I. Jallo, M. Guarnieri
Toxicity and Cerebrospinal Fluid Levels of
Carboplatin Chronically Infused into the Brainstem of a Primate
Journal of Neuro-Oncology, 67 (3): 327-334, May 2004. (Abstract+)
|
|
|
Embryonal
Tumors
|
|
|
|
|
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R,
Milano GM, Garrè ML, Donfrancesco A
A
multimodal strategy based on surgery, radiotherapy, ICE regimen and high
dose chemotherapy in atypical teratoid/rhabdoid tumours: a single
institution experience
J Neurooncol.
2009 Apr;92(2):177-83. Epub 2008 Nov 29
.JPG)
Abstract
|
|
|
Germ
Cell Tumors
|
|
|
|
Kellie SJ,
Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary
chemotherapy for intracranial nongerminomatous germ cell tumors: results of the
second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53
|
|
|
Glioblastoma
|
|
|
|
Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K,
Fukui T, Nakashima Y, Ishikawa M, Hashimoto
N.
Phase II study of nimustine, carboplatin,
vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme:
experience of the Kyoto Neuro-Oncology Group.
J Neurosurg.
2006 Sep;105(3):385-91.
Abstract
|
|
Tomokazu Aoki,
Tetsuya Ueba, Jun Takahashi, Natstuo Ooya, Masahiro Hiraoka, Masatsune Ishikwa,
and Nobuo Hashimoto
Vincristine, ACNU, Carboplatin and Interferon Beta with
Radiation (VAC-FERON-R) for Newly Diagnosed Glioblastoma Multiforme
15th International Conference on Brain Tumor Research and Therapy. Sorrento,
Italy. May 24–27, 2003. Abstract No. 3
Neuro-Oncology, Volume 5, CNO 4, October 2003
|
|
Levin
VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds
N, Woo S, Rodriguez L, et al
Phase II
study of accelerated fractionation radiation therapy with carboplatin
followed by vincristine chemotherapy for the treatment of glioblastoma
multiforme
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64
|
|
J. M. Simon, G. Noel, K.
Hoang-Xuan, A. F. Carpentier, K. Mokhtari, S. Racadot, F. Baillet, J. J.
Mazeron
Radiotherapy and concomitant weekly carboplatin
and daily etoposide for patients with inoperable biopsy proven
glioblastoma multiforme
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1544
|
|
Recurrent
Tumors
|
|
|
|
Aoki
T, Mizutani T, Nojima K, Takagi T, Okumura R, Yuba Y, Ueba T, Takahashi JA,
Miyatake SI, Nozaki K, Taki W, Matsutani M
Phase
II study of ifosfamide, carboplatin, and etoposide in patients with a first
recurrence of glioblastoma multiforme
J Neurosurg.
2009 Jun 19. [Epub ahead of print]
Abstract
|
|
|
de Groot JF, Gilbert MR, Aldape K, Hess KR,
Hanna TA, Ictech S, Groves MD, Conrad C, Colman H, Puduvalli VK, Levin V,
Yung WK
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in
patients with recurrent glioblastoma
J Neurooncol. 2008 Jun 26; [Epub ahead of print]
Abstract
|
|
|
Francesconi
AB, Dupre S, Matos M, Martin D, Hughes BG, Wyld DK, Lickliter JD
Carboplatin and etoposide combined with bevacizumab for the treatment of
recurrent glioblastoma multiforme
J Clin Neurosci. 2010 Jun 9;. [Epub ahead of print]
Abstract
|
|
Jo
Glass, Gruber Michael , Anit Nirenberg
Phase I/II Study of
Carboplatin and Thalidomide in Recurrent Glioblastoma Multiforme
ASCO
Proceedings, 1999 Annual Meeting, Abstract
|
|
|
Reardon
DA, Desjardins A, Peters KB, Gururangan S, Sampson JH, McLendon RE, Herndon
JE 2nd, Bulusu A, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS.
Phase II study of
carboplatin, irinotecan, and bevacizumab for bevacizumab
naïve,
recurrent glioblastoma.
J Neurooncol. 2011 Oct
11;. [Epub ahead of print]
Abstract |
.gif) Related articles
|
|
|
White E, Bienemann A, Taylor H, Hopkins K, Cameron A, Gill S.
A phase I trial of carboplatin administered by convection-enhanced
delivery to patients with recurrent/progressive glioblastoma multiforme.
Contemp Clin Trials. 2011 Nov 12;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliofibroma
|
|
|
|
C.
R. Suarez, S. J. Bertolone
Carboplatinum
(CBDCA), vincristine (V) therapy for CNS gliofibroma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 461
|
|
|
Gliomas
|
|
|
|
Giovanna Cavallo, Luciano Scopece,
Enrico Franceschi, Roberta Degli Esposti, Elisabetta Setola, Cesare Calandri,
Samir Darwish, Lucio Crino
Phase
II trial with carboplatin (CBCDA) and etoposide (VP-16) in recurrent high grade
gliomas
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
307
|
|
Cloughesy TF, Black
KL, Gobin YP, Farahani K, Nelson G, Villablanca P, Kabbinavar F, Vineula F,
Wortel CH
Intra-arterial
Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent
malignant gliomas
Neurosurgery
1999 Feb;44(2):270-8
|
|
Elpis Mantadakis, Maria Raissaki,
Vassiliki Danilatou, Alexander Kambourakis, Eftichia Stiakaki and Maria Kalmanti
Remission of a chiasmatic glioma in
a non-NF1 patient after brief chemotherapy with vincristine and carboplatin:
case report and literature review
J Neurooncol. 2004 Mar-Apr;67(1-2):95-100. (Abstract+)
|
|
Mastronardi
L, Puzzilli F, Couldwell WT, Farah JO, Lunardi P.
Tamoxifen
and carboplatin combinational treatment of high-grade gliomas. Results of a
clinical trial on newly diagnosed patients
J
Neurooncol 1998 May;38(1):59-68
|
|
Prados MD, Schold SC JR SC, Fine HA, Jaeckle K, Hochberg F,
Mechtler L, Fetell MR, Phuphanich S, Feun L, Janus TJ, Ford K, Graney W
A
randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in
combination with carboplatin administered intravenously for the treatment
of recurrent malignant glioma
Neuro-oncol. 2003 Apr;5(2):96-103
|
|
|
P. Tang, G. Roldan,
P.M.A Brasher, D. Fulton, W. Roa, A. Murtha, J.G. Cairncross
and P.A. Forsyth
A phase II study of carboplatin and chronic high-dose tamoxifen in
patients with recurrent malignant glioma
J Neurooncol. 2006 May 19;
[Epub ahead of print]; DOI: 10.1007/s11060-005-9104-y
Abstract
|
|
Yung WK,
Mechtler L, Gleason MJ
Intravenous
carboplatin for recurrent malignant glioma: a phase II study
J Clin Oncol 1991 May;9(5):860-4
|
|
|
Gliomas
(High-Grade)
|
|
|
|
Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner
P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet
JC, Raquin MA, Kalifa C.
High-grade glioma in children under 5 years of age: A
chemotherapy only approach with the BBSFOP protocol.
Eur J Cancer.
2006 Sep 6; [Epub ahead of print]
Abstract
|
|
Recurrent
Tumors
|
|
|
|
Murray LJ, Bridgewater CH, Levy D.
Carboplatin Chemotherapy in Patients with Recurrent High-grade Glioma.
Clin Oncol (R Coll Radiol). 2010 Oct 15;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Schäfer N, Tichy J, Thanendrarajan S, Kim Y, Stuplich M, Mack F, Rieger J,
Simon M, Scheffler B, Boström J, Steinbach JP, Herrlinger U, Glas M.
Ifosfamide,
Carboplatin and Etoposide in Recurrent Malignant Glioma.
Oncology. 2011 Jul
27;80(5-6):330-332. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
Lafay-Cousin L, Holm S, Qaddoumi I, Nicolin G, Bartels U, Tabori U, Huang
A, Bouffet E
Weekly vinblastine in pediatric low-grade glioma patients
with carboplatin allergic reaction
Cancer.
2005 Apr 28; [Epub ahead of print]
|
|
|
Ronghe
M, Hargrave D, Bartels U, Tabori U, Vaidya S, Chandler C, Kulkarni A,
Bouffet E.
Vincristine and carboplatin chemotherapy for unresectable and/or recurrent
low-grade astrocytoma of the brainstem
Pediatr Blood Cancer. 2010 May 26;. [Epub ahead of print]
Abstract
|
|
Sridharan Gururangan, Christina
M. Cavazos, David Ashley, James E. Herndon, II,
Carol S. Bruggers, Albert Moghrabi, Deborah
L. Scarcella, Melody Watral, Sandra Tourt-Uhlig,
David Reardon, Henry S. Friedman
Phase II Study of Carboplatin
in Children With Progressive Low-Grade Gliomas
.
(Abstract+)
|
|
|
Medulloblastoma
|
|
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
479
|
|
|
Metastatic
Tumors
|
|
|
|
D. Y. Kim, K. W. Lee, T. Yun,
J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of
platinum-based chemotherapy after cranial irradiation in patients with brain
metastasis from non-small cell lung cancer
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575
|
|
Jane W. Marsh,
Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in
vitro response to
chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January
2004
|
|
Robert
Morgan Jr., Timothy Synold, Adam Mamelak, Kim Margolin, Al-Kadhimi Zaid,
Przemyslaw Twardowski, Lucille Leong, Dean Lim, Sandeep Reddy, Isan Chen, Warren
Chow, Stephen Shibata, George Somlo, Yun Yen, Paul Frankel, James H Doroshow
Phase
I trial of tamoxifen (Tam), carboplatin (C), and topotecan (T) in recurrent or
metastatic brain tumors
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2102
|
|
|
Oligod.
T. & Mixed Gliomas
|
|
|
|
U.
Basso, F. Vastola, L. M. Pasetto, A. Scola, M. Ermani, M. Cacciacarne, F.
Sala, A. Talacchi, M. K. Paris, A. A. Brandes
Carboplatin
and VM-26 as third-line chemotherapy in patients with oligodendroglioma
refractory to PCV and temozolomide
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 433
|
|
A. A. Brandes, U. Basso, F. Vastola, A. Tosoni, L. M. Pasetto, A. Jirillo,
S. Lonardi, M. K. Paris, H. Koussis, S. Monfardini and M. Ermani
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent
oligodendroglioma or oligoastrocytoma: a phase II study
Annals
of Oncology 14:1727-1731, December 2003
|
|
L. Scopece, G. Cavallo, E.
Palmerini, E. Franceschi, A. Paioli, F. Spagnolli, S. Rimondini, R. Conforti, R.
Degli Esposti, L. Crino
Carboplatin and etoposide (CE) chemotherapy in
patients with recurrent or progressive oligodendroglial tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1562
|
|
Soffietti R, Nobile M, Ruda R, Borgognone M, Costanza A,
Laguzzi E, Mutani R
Second-line treatment with carboplatin for
recurrent or progressive oligodendroglial tumors after PCV (procarbazine,
lomustine, and vincristine) chemotherapy: a phase II study
Cancer. 2004 Feb 15;100(4):807-13
|
|
|
Pediatric
Patients
|
|
|
|
|
Fouladi M, Gururangan S, Moghrabi A, Phillips P,
Gronewold L, Wallace D, Sanford RA, Gajjar A, Kun LE, Heideman R
Carboplatin-based primary chemotherapy for infants and young children
with CNS tumors
Cancer. 2009 Jul
15;115(14):3243-53
Abstract
|
|
|
López-Aguilar E, Sepúlveda-Vildósola AC,
Betanzos-Cabrera Y, Rocha-Moreno YG, Gascón-Lastiri G, Rivera-Márquez H,
Wanzke-Del-Angel V, Cerecedo-Díaz F, Cruz-Yañez Hde L.
Phase II Study of Metronomic Chemotherapy with Thalidomide,
Carboplatin-Vincristine-Fluvastatin in the Treatment of Brain Stem Tumors in
Children
Arch Med Res. 2008 Oct;39(7):655-62; Epub 2008 Aug 17
Abstract
|
|
|
K. Warren,
R. Jakacki, B. Widemann, A. Aikin,
M. Libucha, R. Packer, G. Vezina,
G. Reaman, D. Shaw, M. Krailo,
C. Osborne, J. Cehelsky, D. Caldwell,
J. Stanwood, S. M. Steinberg and F. M. Balis
Phase II trial of intravenous lobradimil and carboplatin in childhood
brain tumors: a report from the Children’s Oncology Group
Cancer Chemotherapy and Pharmacology, Vol. 58, No. 3, Sept 2006; DOI: 10.1007/s00280-005-0172-7;
Pub. Online: 12 January 2006
Abstract
|
|
|
|
